Indian generic drugmaker settles lawsuit with Leo Pharma

Glenmark, an Indian developer of generic medicines, has agreed to a confidential settlement with Leo Pharma concerning a generic version of the Danish firm’s foam treatment for plaque psoriasis.
Photo: Leo Pharma/PR
Photo: Leo Pharma/PR
by ulrich quistgaard, translated by daniel pedersen

Leo Pharma’s lawsuit against Indian generic drugmaker Glenmark has concluded in a settlement, Leo Pharma informs MedWatch by email.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading